Hepatitis C virus infection in dialysis and renal transplantation
BJG Pereira, AS Levey - Kidney international, 1997 - Elsevier
Liver disease is an important cause of morbidity and mortality in patients with chronic renal
failure treated by dialysis and transplantation [1—101. Elevated serum alanine …
failure treated by dialysis and transplantation [1—101. Elevated serum alanine …
Blood‐borne virus infections in dialysis units—A review
TG Wreghitt - Reviews in medical virology, 1999 - Wiley Online Library
Hepatitis outbreaks in haemodialysis unit patients and staff were reported in the late 1960s.
In 1972, the Rosenheim report in the UK established guidelines which included routine tests …
In 1972, the Rosenheim report in the UK established guidelines which included routine tests …
Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients
H Hinrichsen, G Leimenstoll, G Stegen, H Schrader… - Gut, 2002 - gut.bmj.com
Background: Hepatitis C virus (HCV) infection is a significant problem in the management of
haemodialysis patients. A high prevalence of HCV infection in haemodialysis patients has …
haemodialysis patients. A high prevalence of HCV infection in haemodialysis patients has …
Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis
F Fabrizi, G Lunghi, S Finazzi, P Colucci… - American journal of …, 2001 - Elsevier
Hepatitis C virus (HCV) infection is common in the dialysis population and patients with
chronic renal failure (CRF) not requiring dialysis. HCV is the most important cause of chronic …
chronic renal failure (CRF) not requiring dialysis. HCV is the most important cause of chronic …
Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors
WA Alashek, CW McIntyre, MW Taal - BMC infectious diseases, 2012 - Springer
Background Patients receiving maintenance haemodialysis (HD) are at higher risk for
acquiring Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) infections than the general …
acquiring Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) infections than the general …
High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with …
J Bukh, P Wantzin, K Krogsgaard… - Journal of Infectious …, 1993 - academic.oup.com
Results of serologic tests were correlated with hepatitis C virus (HCV) viremia, determined
by a cDNA polymerase chain reaction assay to detect HCV RNA, in 340 Danish dialysis …
by a cDNA polymerase chain reaction assay to detect HCV RNA, in 340 Danish dialysis …
The impact of hepatitis C virus infection on renal allograft recipients
The impact of hepatitis C virus infection on renal allograft recipients. A second generation
hepatitis C virus recombinant immunoblot assay (RIBA) was used to screen stored …
hepatitis C virus recombinant immunoblot assay (RIBA) was used to screen stored …
Hepatitis virus infection in haemodialysis patients from Moldavia.
BACKGROUND: Although the epidemiology of hepatitis B (HBV) and C (HCV) now seems
well established for Western European countries, in Central and Eastern Europe< 50% of all …
well established for Western European countries, in Central and Eastern Europe< 50% of all …
Renal manifestations of hepatitis C infection
L Daghestani, C Pomeroy - The American journal of medicine, 1999 - Elsevier
Hepatitis C is an important cause of renal disease, and renal complications may be the
presenting manifestation of hepatitis C infection. About half of patients present with evidence …
presenting manifestation of hepatitis C infection. About half of patients present with evidence …
A twelve year natural history of hepatitis C virus infection in hemodialyzed patients
N Simon, AM Couroucé, N Lemarrec, C Trépo… - Kidney international, 1994 - Elsevier
A twelve year natural history of hepatitis C virus infection in hemodialyzed patients. A
prospective non-A, non-B follow-up program, implemented in a hepatitis B surface antigen …
prospective non-A, non-B follow-up program, implemented in a hepatitis B surface antigen …